Steven Cohen Edgewise Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 50,000 shares of EWTX stock, worth $741,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,000
Previous 106,562
53.08%
Holding current value
$741,000
Previous $2.85 Million
61.34%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$223 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$132 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$97 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$91.2 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$89.2 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $936M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...